medigraphic.com
ISSN 2448-8909 (Print)

2023, Number 3

<< Back

Med Crit 2023; 37 (3)

Arrhythmic storm associated with COVID-19; literature review and case report in Mexico

López FJ, Ortega DDV, Flores SLS, Cisneros RJÁ, Zamorano LCA, Pulido SFJ, Peña JJ, Osuna ZKR, Guerrero SJ, Pérez NOR

Language: Spanish
References: 25
Page: 262-267
PDF size: 209.98 Kb.


ABSTRACT

Arrhythmias are one of the main causes of death in the Intensive Care Unit (ICU). During the COVID-19 pandemic, multiple complications have been reported in patients, especially those in critical condition, in which various factors have been associated with their development. Arrhythmic storm is a serious and potentially lethal condition, with a not entirely clear pathophysiology, requiring an early identification of potential modifiable and preventable risk factors, since once the condition is installed, survival is minimal. A case report is presented based on the CARE guidelines of a 22-year-old male, diagnosed with critical COVID-19, who develops episodes of tachyarrhythmias during his hospitalization, which meets the diagnostic criteria for arrhythmic storm.


REFERENCES

  1. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15(10):e190-e252. doi: 10.1016/j.hrthm.2017.10.035.

  2. Kowlgi GN, Cha YM. Management of ventricular electrical storm: a contemporary appraisal. Europace. 2020;22(12):1768-1780. doi: 10.1093/europace/euaa232)

  3. Fries R, Heisel A, Huwer H, et al. Incidence and clinical significance of short-termrecurrent ventricular tachyarrhythmias in patients with implantable cardioverterdefibrillator. Int J Cardiol. 1997;59(3):281-284.

  4. Exner DV, Pinski SL, Wyse DG, et al. Electrical storm presages nonsudden death. Circulation. 2001;103(16):2066-2071.

  5. Verma A, Kilicaslan F,Marrouche NF, et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol. 2004;15(11):1265-1270.

  6. Hohnloser SH, Al-Khalidi HR, Pratt CM, et al. Electrical stormin patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J. 2006;27(24):3027-3032.

  7. Sesselberg HW, Moss AJ, McNitt S, et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm. 2007;4(11):1395-1402.

  8. Nordbeck P, Seidl B, Fey B, Bauer WR, Ritter O. Effect of cardiac resynchronization therapy on the incidence of electrical storm. Int J Cardiol. 2010;143(3):330-336.

  9. Guerra F, Palmisano P, DellEra G, et al. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On longterm outcome of ICD patients (OBSERVO-ICD). Heart Rhythm. 2016;13(10):1987-1992.

  10. Elsokkari I, Parkash R, Tang A, et al. Mortality risk increases with clustered ventricular arrhythmias in patients with implantable cardioverter-defibrillators. JACC: Clinical Electrophysiology. 2020;6(3):327-337.

  11. Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020; 133:1025.

  12. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352.

  13. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061.

  14. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811.

  15. Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17:1439.

  16. Shao F, Xu S, Ma X, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020;151:18.

  17. Cho JH, Namazi A, Shelton R, et al. Cardiac arrhythmias in hospitalized patients with COVID-19: a prospective observational study in the western United States. PLoS One. 2020;15:e0244533.

  18. Naranjo-Domínguez A, Valdés-Martín A, Crespo I, et al. Normas de publicación y guía para autores. Actualización 2021. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2021;27(3):e1235.

  19. Gutiérrez LA, Cruz CM, Mengana BA, et al. Arritmias cardiacas en pacientes con la COVID-19 Escenarios y tratamiento. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2020;26(3):e1006.

  20. Taqi H. COVID-19: Cardiac Arrhythmias. British Cardiovascular Society. 2020. Retrieved from: https://www.britishcardiovascularsociety.org/resources/editorials/articles/covid-19-cardiac-arrhythmias

  21. Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, arrhythmic risk, and inflammation: mind the gap. Circulation. 2020;142(1):7-9. doi: 10.1161/CIRCULATIONAHA.120.047293.

  22. Elsaid O, McCullough PA, Tecson KM, Williams RS, Yoon A. Ventricular fibrillation storm in coronavirus 2019. Am J Cardiol. 2020; 135:177-180. doi: 10.1016/j.amjcard.2020.08.033

  23. Dherange P, Lang J, Qian P, et al. Arrhythmias and COVID-19: a review. JACC Clin Electrophysiol. 2020;6(9):1193-1204. doi: 10.1016/j.jacep.2020.08.002.

  24. Dyer S, Mogni B, Gottlieb M. Electrical storm: a focused review for the emergency physician. Am J Emerg Med. 2020;38(7):1481-1487. doi: 10.1016/j.ajem.2020.04.017.

  25. Elsokkari I, Sapp JL. Electrical storm: prognosis and management. Prog Cardiovasc Dis. 2021;66:70-79. doi: 10.1016/j.pcad.2021.06.007.




2020     |     www.medigraphic.com